​

Praxis Precision Medicines (PRAX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Praxis Precision Medicines Revenue Highlights

Latest Revenue (Y)

$8.55M

0

Main Segment (Y)

License

Praxis Precision Medicines Revenue by Period

Praxis Precision Medicines Revenue by Year

DateRevenueChange
2024-12-31$8.55M249.53%
2023-12-31$2.45M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Praxis Precision Medicines generated $8.55M in revenue during NA 2024, up 249.53% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Praxis Precision Medicines Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$7.46M2371.19%
2024-09-30$302.00K-15.41%
2024-06-30$357.00K-17.17%
2024-03-31$431.00K-16.31%
2023-12-31$515.00K10.04%
2023-09-30$468.00K-40.08%
2023-06-30$781.00K14.35%
2023-03-31$683.00K100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Praxis Precision Medicines generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Praxis Precision Medicines Revenue Breakdown

Praxis Precision Medicines Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22
License$8.60M$2.40M$98.50M
Upfront Payment$2.60M--

Praxis Precision Medicines's latest annual revenue breakdown by segment (product or service), as of Dec 24: License (76.79%), and Upfront Payment (23.21%).

Quarterly Revenue by Product

Product/ServiceDec 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23
Option Exercise Fee$6.00M------
License-$400.00K$400.00K$400.00K$500.00K$800.00K$700.00K

Praxis Precision Medicines's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Option Exercise Fee (100.00%).

Praxis Precision Medicines Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ACADACADIA Pharmaceuticals$957.80M$278.63M
LGNDLigand Pharmaceuticals$167.13M$115.46M
KYMRKymera Therapeutics$47.07M$2.76M
PRAXPraxis Precision Medicines$8.55M-
CRNXCrinetics Pharmaceuticals$1.04M$143.00K
XENEXenon Pharmaceuticals--
AKROAkero Therapeutics--
SLNOSoleno Therapeutics-$66.02M
VKTXViking Therapeutics--
IMVTImmunovant--
CNTACentessa Pharmaceuticals--

PRAX Revenue FAQ

What is Praxis Precision Medicines’s yearly revenue?

Praxis Precision Medicines's yearly revenue for 2024 was $8.55M, representing an increase of 249.53% compared to 2023. The company's yearly revenue for 2023 was $2.45M, representing an increase of 100.00% compared to 2022. PRAX's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Praxis Precision Medicines’s quarterly revenue?

Praxis Precision Medicines's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a -100.00% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a -100.00% decrease year-over-year (Q2 2024). PRAX's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a -100.00% decrease year-over-year (Q1 2024).

What is Praxis Precision Medicines’s revenue growth rate?

Praxis Precision Medicines's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.

What are Praxis Precision Medicines’s revenue streams?

Praxis Precision Medicines's revenue streams in c 24 are License, and Upfront Payment. License generated $8.6M in revenue, accounting 76.79% of the company's total revenue, up 258.33% year-over-year. Upfront Payment generated $2.6M in revenue, accounting 23.21% of the company's total revenue

What is Praxis Precision Medicines’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Praxis Precision Medicines was License. This segment made a revenue of $8.6M, representing 76.79% of the company's total revenue.